Report
Richard Gill, CFA

WideCells Group - Initiation of coverage

WideCells Group is a Main Market listed healthcare services company focused on growing in the burgeoning market for stem cell services. Over the past few years, management have built up an integrated stem cell services provider, focused on providing products which make stem cell treatments accessible and affordable.

Underlying
Iconic Labs

WideCells Group is a stem cell services company, focused on making stem cell treatments accessible and affordable. Co. has created three divisions: CellPlan, WideCells and WideAcademy. CellPlan: This is a stem cell healthcare insurance plan providing financial cover and recommendation of transplant center, private cord blood transplantation costs, travel to treatment center, accommodation expenses and concierge service to manage the whole transplant process. WideCells: The focus is on stem cell research and regenerative medicine. WideAcademy: Developing an education and training division to promote understanding of the benefits of stem cell storage and treatment.

Provider
Align Research
Align Research

Align Research is a commissioned research company founded in November 2015 in order to provide the under-served smaller company space with high quality analysis. We have an initial focus on the natural resources sector, in which we see significant opportunities given the current once in a generation bear market, however all undervalued small caps (sub £100m) are considered by our team. Align was founded by industry professionals with decades of experience in the stock markets, headed up by highly qualified individuals from both fund management and analytical backgrounds.

Analysts
Richard Gill, CFA

Other Reports on these Companies
Other Reports from Align Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch